Clinical Trials
A brighter future
Our mission is to advance medicines that will provide a brighter future for patients with serious conditions that are not fully served by existing treatments. Our ability to evaluate the safety and efficacy of new therapies is a fundamental part of the development process. We rely on volunteers to enroll in our studies and are very grateful for their participation.
MAGIC-G1 Clinical Trial for patients suffering with recurrent glioblastoma
Currently open for recruitment at two US hospitals, in North Carolina and Florida, the MAGIC-G1 trial is a phase I study investigating the safety of an experimental drug known as MTX110. In the MAGIC-G1 clinical trial, MTX110 is administered directly to the site of the tumor using a technique called convection-enhanced delivery (CED).